Physician profile
Mystical Evans
NPI 1982338737
$1,196.11
in general payments reported to CMS, 2019-2025
17 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.89 · 2023: $149 · 2024: $721 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.55 | 2023-2024 | |
| Novo Nordisk INC | $153.58 | 2024 | Ozempic, Wegovy, Fiasp |
| Scpharmaceuticals INC. | $149.95 | 2025 | |
| Edwards Lifesciences Corporation | $143.81 | 2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $108.22 | 2024 | |
| Astellas Pharma US INC | $75.55 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $74.64 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $54.51 | 2022-2024 | Farxiga, Airsupra |
| Exact Sciences Corporation | $50.24 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.16 | 2023-2024 | Ofev, Jardiance |
| Lilly USA, LLC | $46.82 | 2022-2023 | Mounjaro |
| Radius Health, INC. | $30.03 | 2023 | Tymlos |
| Saluda Medical Americas, INC. | $24.22 | 2024 | Evoke |
| Glaxosmithkline, LLC. | $15.05 | 2024 | Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $14.97 | 2024 | Intellis Adaptivestim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.86 | 2024 | Livalo |
| Shield Therapeutics INC | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mystical Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.